- Home
- ISDR vs SRZN Comparison
ISDR vs SRZN Comparison
Compare ISDR & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISDR
- SRZN
- Stock Information
- Founded
- ISDR 1988
- SRZN 2015
- Country
- ISDR United States
- SRZN United States
- Employees
- ISDR N/A
- SRZN N/A
- Industry
- ISDR Publishing
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- ISDR Consumer Discretionary
- SRZN Health Care
- Exchange
- ISDR Nasdaq
- SRZN Nasdaq
- Market Cap
- ISDR 35.0M
- SRZN 38.1M
- IPO Year
- ISDR N/A
- SRZN N/A
- Fundamental
- Price
- ISDR $9.22
- SRZN $11.70
- Analyst Decision
- ISDR
- SRZN Strong Buy
- Analyst Count
- ISDR 0
- SRZN 1
- Target Price
- ISDR N/A
- SRZN $45.00
- AVG Volume (30 Days)
- ISDR 15.0K
- SRZN 51.3K
- Earning Date
- ISDR 03-06-2025
- SRZN 11-06-2024
- Dividend Yield
- ISDR N/A
- SRZN N/A
- EPS Growth
- ISDR N/A
- SRZN N/A
- EPS
- ISDR N/A
- SRZN N/A
- Revenue
- ISDR $29,141,000.00
- SRZN $10,000,000.00
- Revenue This Year
- ISDR N/A
- SRZN N/A
- Revenue Next Year
- ISDR N/A
- SRZN N/A
- P/E Ratio
- ISDR N/A
- SRZN N/A
- Revenue Growth
- ISDR N/A
- SRZN N/A
- 52 Week Low
- ISDR $7.61
- SRZN $6.00
- 52 Week High
- ISDR $16.92
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- ISDR 51.12
- SRZN 48.38
- Support Level
- ISDR $8.54
- SRZN $10.20
- Resistance Level
- ISDR $9.60
- SRZN $13.28
- Average True Range (ATR)
- ISDR 0.47
- SRZN 1.98
- MACD
- ISDR 0.09
- SRZN -0.23
- Stochastic Oscillator
- ISDR 71.64
- SRZN 20.22
About ISDR Issuer Direct Corporation
Issuer Direct Corp is a communications and compliance company. It focuses on the needs of corporate issuers. It provides disclosure management solutions, shareholder communications tools, and cloud-based compliance technologies. Its customers include public and private companies, mutual funds, law firms, brokerage firms, investment banks, individuals, and other institutions. Its products include PR solutions, IR solutions, Compliance, and Event management software.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).